Clinical trial

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate…

NCT00075725 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00075725
Title Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Official title High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
Intervention type Drug, Radiation
Interventions Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone and 3 more
Enrollment 3,154
Start date Dec 29, 2003
Primary completion Dec 31, 2010
Completion Mar 31, 2021
First posted Jan 13, 2004
Last update posted Apr 27, 2021
Countries Australia, Canada, New Zealand, Switzerland, United States

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies